According to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill., breast cancer treatments known as aromatase inhibitors may reduce the effect of weight reduction therapies.
Washington [US], March 21 (ANI): Commonly used medications for type 2 diabetes and obesity called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to a study p
Moscow [Russia], Aug 5 (ANI): A team of chemists used molecular modelling to find out that two medications that have been known for a long time can be used to fight SARS-CoV-2. These are disulfiram, which is used to treat alcoholism, and neratinib, an experimental drug being used to treat br